Return to homepagePandemic Pact

Pre-clinical development of a COVID-19 vaccine for New Zealand and global use - candidate selection

Grant number: CVCOR2002

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2021

  • Known Financial Commitments (USD)

    $285,309.37

  • Funder

    Callaghan Innovation

  • Research Location

    New Zealand

  • Lead Research Institution

    Covid-19 Vaccine Corporation Limited

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract